1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Marfan Syndrome Global Clinical Trials Review, H2, 2015

Marfan Syndrome Global Clinical Trials Review, H2, 2015

  • August 2015
  • -
  • Global Data
  • -
  • 72 pages

Marfan Syndrome Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Marfan Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Marfan Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Marfan Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Marfan Syndrome Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Marfan Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Marfan Syndrome 20
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Marfan Syndrome Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Merck and Co., Inc. 27
Clinical Trial Overview of Merck and Co., Inc. 27
A. Menarini Industrie Farmaceutiche Riunite Srl 28
Clinical Trial Overview of A. Menarini Industrie Farmaceutiche Riunite Srl 28
Clinical Trial Overview of Top Institutes / Government 29
Academic Medical Center 29
Clinical Trial Overview of Academic Medical Center 29
Ann and Robert H. Lurie Children's Hospital of Chicago 30
Clinical Trial Overview of Ann and Robert H. Lurie Children's Hospital of Chicago 30
Assistance Publique - Hopitaux de Paris 31
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 31
Bayside Health 32
Clinical Trial Overview of Bayside Health 32
Brigham and Women's Hospital 33
Clinical Trial Overview of Brigham and Women's Hospital 33
Cardiff University 34
Clinical Trial Overview of Cardiff University 34
Department of Health, South Africa 35
Clinical Trial Overview of Department of Health, South Africa 35
Department of Health, UK 36
Clinical Trial Overview of Department of Health, UK 36
Ghent University Hospital 37
Clinical Trial Overview of Ghent University Hospital 37
IRCCS Policlinico San Matteo 38
Clinical Trial Overview of IRCCS Policlinico San Matteo 38
Five Key Clinical Profiles 39
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

List of Tables
Marfan Syndrome Therapeutics, Global, Clinical Trials by Region, 2015* 7
Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Marfan Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Marfan Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015* 20
Marfan Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Marfan Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Marfan Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 27
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Menarini Industrie Farmaceutiche Riunite Srl, 2015* 28
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 29
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ann and Robert H. Lurie Children's Hospital of Chicago, 2015* 30
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 31
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2015* 32
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2015* 33
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2015* 34
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2015* 35
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015* 36
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2015* 37
Marfan Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico San Matteo, 2015* 38

List of Figures
Marfan Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13
Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Marfan Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Marfan Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 70

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.